PBM | NACDS

NACDS Praises Sens. Wyden, Crapo for Continued Bipartisan Push to Reform “Pharmaceutical Benefit Manipulation” As Senate Finance Committee releases legislative framework, NACDS emphasizes its Principles of PBM Reform to ensure comprehensive and lasting solutions for patients, pharmacies, employers, taxpayers, communities, and the nation

admin2023-04-20T09:59:23-04:00Categories: Press Release|Tags: Congress, DIR, PBM, Reimbursement|

As Senate Finance Committee releases legislative framework, NACDS emphasizes its Principles of PBM Reform to ensure comprehensive and lasting solutions for patients, pharmacies, employers, taxpayers, communities, and the nation.

NACDS Lauds Senate Introduction of ‘Drug Pricing Transparency in Medicaid Act’ Bipartisan – now bicameral – legislation is an important part of a comprehensive approach to stopping PBMs’ “pharmaceutical benefit manipulation”

admin2023-04-03T14:40:45-04:00Categories: Press Release|Tags: Congress, Medicaid, PBM, Reimbursement|

NACDS is lauding legislation introduced by U.S. Senators Peter Welch (D-VT) and Roger Marshall (R-KS) to crack down on tactics by which “pharmaceutical benefit manipulator” middlemen maximize profits at the expense of patients, pharmacies, and others.

NACDS Lauds New York’s Medicaid “Promise Kept” NYRx puts patients over PBMs in the state’s Medicaid pharmacy benefit

admin2023-04-03T12:14:27-04:00Categories: In Case You Missed It, Press Release|Tags: Medicaid, PBM, Reimbursement, States|

NYRx puts patients over PBMs in the state’s Medicaid pharmacy benefit.

NACDS Urges Transparency, Accountability, and Fair Competition as Senate Finance Explores PBMs’ Impact on Healthcare Statement defines specific solutions for patient-manipulation by “PBMs” and urges continued bipartisan work on this critical issue

admin2023-03-30T10:11:58-04:00Categories: Press Release|Tags: Congress, DIR, PBM, Pharmacy Value, Reimbursement|

Statement defines specific solutions for patient-manipulation by “PBMs” and urges continued bipartisan work on this critical issue.

In Case You Missed It: HHS Secretary Xavier Becerra Talks ‘Clever’ PBM Middlemen Tactics During Senate Hearing

admin2023-03-29T17:38:36-04:00Categories: In Case You Missed It|Tags: Congress, DIR, PBM, Reimbursement|

Last week, Health and Human Services (HHS) Secretary Xavier Becerra appeared before the U.S. Senate Appropriations Committee to provide testimony on the FY 2024 Funding Request and Budget Justification of the Department of Health and Human Services.

NACDS Backs Rep. Carter’s Drug Price Transparency in Medicaid Act Says bill is part of bipartisan and comprehensive approach that is emerging to stop “pharmaceutical benefit manipulation” and to put patients over PBM profits

admin2023-12-12T11:11:16-05:00Categories: Press Release|Tags: Congress, Medicaid, PBM, Reimbursement|

The Drug Price Transparency in Medicaid Act will protect patients, pharmacies, and others from middlemen tactics that drive up prescription drug prices.

NACDS Statement in Response to Introduction of PBM Reform Legislation in Florida

admin2023-03-06T16:55:57-05:00Categories: Press Release|Tags: DIR, PBM, Reimbursement, States|

NACDS President and CEO Steven C. Anderson released the following statement today following the introduction of pharmacy benefit manager (PBM) reform legislation (HB 1509/SB 1550) in the Florida legislature:

NACDS Praises New Congressional Investigation of PBMs U.S. House Oversight and Accountability Committee expands bipartisan Congressional push to stop pharmaceutical benefit manipulation by middlemen

admin2023-03-02T08:36:26-05:00Categories: Press Release|Tags: Congress, DIR, PBM, Reimbursement|

U.S. House Oversight and Accountability Committee expands bipartisan Congressional push to stop pharmaceutical benefit manipulation by middlemen.

NACDS Defines “PBM Reform” for Senate Hearing Statement outlines specific solutions to patient-manipulation by “PBMs”

admin2023-02-16T08:00:35-05:00Categories: Press Release|Tags: Congress, DIR, Medicare, PBM, Reimbursement|

Statement outlines specific solutions to patient-manipulation by “PBMs”.

NACDS Statement in Response to State of the Union Address

admin2023-02-08T09:51:29-05:00Categories: Press Release|Tags: DIR, PBM, Pharmacy_Value, Preparedness, Reimbursement, Vaccinations|

While we all want to move on from COVID-19, doing so should not mean leaving behind millions of Americans who have relied on their trusted, local pharmacies for testing, vaccinations, and care during the pandemic.

National Association of Chain Drug StoresPharmacies. The face of neighborhood healthcare.